 mellitus; ESRD,
end-stage renal disease; HbA1c, hobgoblin A1; HLD, hyperlipidemia; HTN, hypertension; ICA, internal carotid artery; LDL, low-density lipoprotein; LOS,
length of stay; MI, myocardial infarction; NR, not reported; NSTEMI, non-ST segment elevation myocardial infarction; PAD, peripheral artery disease;
PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; STEMI, ST segment elevation myocardial infarction; TIA, transient ischemic
attack; VR, valve replacement.

Journal of Vascular Surgery

Hasan et al

108S.e23

Volume 75, Number 1S

Supplementary Table III (online only). Risk of Bias assessment
Selection

Author, year

Outcomes

Random sequence
generation:
(A) Low risk*
(B) High risk
(C) Unclear

Allocation
concealment:
(A) Low risk*
(B) High risk
(C) Unclear

Blinding of
participants
or personnel:
(A) Low risk*
(B) High risk
(C) Unclear

Blinding of
outcome
assessment:
(A) Low risk*
(B) High risk
(C) Unclear

Incomplete
outcome data:
(A) Low risk*
(B) High risk
(C) Unclear

Reporting
bias/selective
reporting:
(A) Low risk*
(B) High risk
(C) Unclear

Other Sources
of bias:
(A) Low risk*
(B) High risk
(C) Unclear

Overall
risk of bias

Low

Question 1: RCTs
ACST, 20045

A

A

C

A

A

A

A

Kolos et al,4 2015

A

A

B

A

A

A

A

Low

Reiff et al, 20191

C

C

B

B

A

A

A

Moderate

Walker et al,3 1995

A

A

B

A

A

A

A

Low

Selection

Author, Year

Comparability

Outcome

Selection of the
Comparability
Adequacy of follow-up:
nonexposed cohort:
of cohorts
(A